⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL156431 | 1.00 | — | — | |
| SCHEMBL847297 | 1.00 | — | — | |
| SCHEMBL154669 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL15796506 | 0.97 | — | — | |
| SCHEMBL5139179 | 0.87 | GABRR1 (0.72) | — | |
| SCHEMBL15228384 | 0.86 | LTA4H (0.50) | — | |
| SCHEMBL1859719 | 0.83 | — | — | |
| SCHEMBL422422 | 0.81 | BLM (0.56) | — | |
| SCHEMBL13554886 | 0.81 | BLM (0.56) | — | |
| SCHEMBL5472712 | 0.81 | BLM (0.55) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11730748-B2 | Cyclic phosphate substituted nucleoside derivatives for the treatment of liver diseases | MSD INTERNATIONAL GMBH (CH) | 2023-08-22 | — | — | US | disclosed |
| US-11730748-B2 | Cyclic phosphate substituted nucleoside derivatives for the treatment of liver diseases | MSD INTERNATIONAL GMBH (CH) | 2023-08-22 | — | — | US | disclosed |
| US-20210205339-A1 | CYCLIC PHOSPHATE SUBSTITUTED NUCLEOSIDE DERIVATIVES FOR THE TREATMENT OF LIVER DISEASES | MSD INTERNATIONAL GMBH (CH) | 2021-07-08 | — | — | US | disclosed |
| US-10766917-B2 | Nucleotides for the treatment of cancer | IDENIX PHARMACEUTICALS LLC (US) | 2020-09-08 | — | — | US | disclosed |
| EP-3541825-A1 | CYCLIC PHOSPHATE SUBSTITUTED NUCLEOSIDE DERIVATIVES FOR THE TREATMENT OF LIVER DISEASES | Idenix Pharmaceuticals LLC. (US) | 2019-09-25 | — | — | EP | disclosed |
| US-20180155385-A1 | NUCLEOTIDES FOR THE TREATMENT OF CANCER | IDENIX PHARMACEUTICALS LLC (US) | 2018-06-07 | — | — | US | disclosed |
| WO-2018091542-A1 | CYCLIC PHOSPHATE SUBSTITUTED NUCLEOSIDE DERIVATIVES FOR THE TREATMENT OF LIVER DISEASES | IDENIX PHARMACEUTICALS LLC (US) | 2018-05-24 | — | — | WO | disclosed |
| EP-3303359-A1 | NUCLEOTIDES FOR THE TREATMENT OF CANCER | Idenix Pharmaceuticals LLC (US) | 2018-04-11 | — | — | EP | disclosed |
| WO-2016188943-A1 | NUCLEOTIDES FOR THE TREATMENT OF CANCER | IDENIX PHARMACEUTICALS LLC (US) | 2016-12-01 | — | — | WO | disclosed |
| CN-102010403-A | Total Synthesis of pladienolide B and pladienolide D | EISAI R&D MAN CO LTD | 2011-04-13 | — | — | CN | disclosed |
| CN-101282967-B | Total synthesis of pladienolide b and pladienolide D | EISAI R&D MAN CO LTD | 2011-01-26 | — | — | CN | disclosed |
| CN-101282967-A | Total synthesis of pladienolide b and pladienolide D | EISAI R&D MAN CO LTD (JP) | 2008-10-08 | — | — | CN | disclosed |
| EP-0855935-B1 | CHIRAL SOLID CATALYST, ITS PREPARATION AND ITS USE FOR THE PRODUCTION OF SUBSTANTIALLY ENANTIOMERICALLY PURE PRODUCTS | LEUVEN K U RES & DEV (BE) | 2001-06-27 | — | — | EP | disclosed |
| US-5997840-A | A BEA TOPOLOGY ZEOLITE AND A METAL-BINAP COMPLEX | K.V. LEUVEN RESEARCH & DEVELOPMENT (BE) | 1999-12-07 | — | — | US | disclosed |
| EP-0855935-A1 | CHIRAL SOLID CATALYST, ITS PREPARATION AND ITS USE FOR THE PRODUCTION OF SUBSTANTIALLY ENANTIOMERICALLY PURE PRODUCTS | K.U. Leuven Research & Development (BE) | 1998-08-05 | — | — | EP | disclosed |
| WO-1997014500-A1 | CHIRAL SOLID CATALYST, ITS PREPARATION AND ITS USE FOR THE PRODUCTION OF SUBSTANTIALLY ENANTIOMERICALLY PURE PRODUCTS | K.U. LEUVEN RESEARCH & DEVELOPMENT (BE) | 1997-04-24 | — | — | WO | disclosed |